1. Lillian Pothier, Warren W. Lane, Arvind Bhargava, Conrad Michielson, Harold Douglass Plasma selenium levels in patients with advanced upper gastrointestinal cancer. Cancer November 1987; 60 (9): 2251–60.
2. Nikolay V. Dimitrov, Leigh J. Charamella, Cheryl J. Meyer et al. Ku and Duane E. Ullrey Modulation of natural killer cell activity by selenium in humans. Journal of nutrition, growth and cancer 1986; 3: 193–8.
3. Lidia Kiremidjian-Scumacher, Martin Roy, Harvey I. Wishe et al. Supplementation with selenium and human immune cell functions II. Effect on cytotoxic lymphocytes and natural killer cells. Biological trace element research 1994; 41: 115–27.
4. Caroline S. Broome, Francis Mc Ardle, Janet A.M. Kyle et al. Jackson An increase in selenium intake improves immune function and poliovirus handling in adults with marginal selenium status. 2004; 80: 154–62.
5. Shu-Yu Yu, Ya-Jun-Zhu, Wen-Guang Li et al. A preliminary report on the intervention trials of primary liver cancer in high-risk populations with nutritional supplementation of selenium in China. Biological trace element research 1991; 29: 289–94.
6. Tara M. Vogt, Regina G. Ziegler, Barry I. Graubard et al. Serum selenium and risk of prostate cancer in U.S. blacks and whites. Int J Cancer 2003; 103: 664–70.
7. Piet A van den Brandt, Maurice P. A. Zeegers, Peter Bode, R. Alexandra Goldbohm. Toenail Selenium Levels and the Subsequent Risk of Prostate Cancer: A Prospective Cohort Study. Cancer Epidemiology, Btomarkers & Prevention. September 2003; 12: 866–71.
8. James D. Brooks, E. Jeffrey Metter, Daniel W. Chan et al. Plasma selenium level before diagnosis and the risk of prostate cancer development. The journal of urology®. December 2001; 166: 2034–8.
9. Oliver H. Al-Taie, Jochen Seufert, Serhan Karvar et al. Selenium supplementation enhances low selenium levels andstimulates glutathione peroxidase activity in peripheral blood anddistal colon mucosa in past and present carriers of colon adenomas. Nutrition and cancer 2003; 46 (2): 125–30.
10. Psathakis D, Wedemeyer N, f Oevermann E et al. Blood Selenium and Glutathione Peroxidase Status in Patients with Colorectal Cancer. Selenium in colorectal cancer patients 1998; 41 (3): 328–34.
11. Pakdman A. Symptomatic treatment of brain tumor patients with sodium selenite, oxygen, and other supportive measures. Biological trace element research 1998; 62: 1–6.
12. Ya-Jun Hu, Yan Chen, Yong-Qiang Zhang et al. The protective role of selenium on the toxicity of cisplatin-contained chemotherapy regimen in cancer patients. Biological trace element research 1997; 56: 331–40.
13. Mueche R, Micke O, Berndt-Skorka R et al. Einsatz von Natriumselenit in der radioonkologie – klinische Phase-III-Studie bei der postoperativen RT gynaekologiscger Tumoren Stand 12/2004. Strahlenther Onkol 2005; 17 (1): 181.
14. Caffrey PB, Frenkel GD. Selenium compounds prevent the induction of resistence by cisplatin in human ovarian tumor xenografts in vivo. Cancer Chemoth prarmakol 2000; 46: 74–8.
15. Lanfear J, Fleming J, Wu L et al. The selenium metabolite selenodiglutathion induces p53 and apoptosis: relevance to the chemopreventive effects of selenium? Cancinogenecis 1994; 15: 1387–92.
16. Kasseroller R. Natriumselenit in der therapie des chronischen lymphodems. Der Allgemeinarzt 1995; 17: 1396–404.

И.Н.Огнерубова, И.В.Поддубная

Кафедра онкологии ГОУ ДПО РМАПО, Москва